Clonorchis sinensis, as a liver fluke, can cause chronic liver damage, liver fibrosis, and even cholangiocarcinoma (CCA). However, there is a lack of effective therapeutic approaches for the treatment of clonorchiasis. Thus, we aimed to investigate the role of long noncoding RNAs (lncRNAs) in liver fibrosis induced by C. sinensis and evaluate the therapeutic potential of GalNAc-modified siRNAs targeting these lncRNAs. In this study, we first isolated Clonorchis sinensis extracellular vesicles (CsEVs) and identified the fibrosis-related long noncoding RNA lnc28240.1 in the CsEVs. In vitro and in vivo experiments revealed that the CsEVs and lnc28240.1 could induce liver fibrosis. Thus, to inhibit the development of liver fibrosis, we designed and synthesized a short interfering RNA#1 (siRNA#1) modified with N-acetylgalactosamine (GalNAc) to silence the pathogenic gene lnc28240.1. The results demonstrated that the GalNAc-siRNA conjugates effectively silenced lnc28240.1, significantly reducing C. sinensis-induced liver fibrosis and normalizing liver function. Our findings suggest that GalNAc-siRNA for gene silencing of parasite-derived lncRNA is a promising therapeutic strategy for the treatment of liver fibrosis caused by C. sinensis.
Keywords: Clonorchis sinensis; N-acetylgalactosamine; Short interfering RNA.
Copyright © 2025. Published by Elsevier B.V.